RxDoctor Payments Data

Diljon Chahal, MD

Interventional Cardiology · Baltimore, MDNPI 1184883217

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $52,705 of the $77,916 with a category attached, or 67.6%. Edwards Lifesciences accounts for 89.5% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $30,640, 7.2 times the $4,227 reported in 2019. Among interventional cardiology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$77,916in general payments, 2019–2025

Across 252 payments — averaging $309.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$70K
  • Abbott$2K
  • Boston Scientific$2K
  • Medtronic$1K
  • Shockwave Medical, Inc$1K
  • Abiomed$352
  • plus $1K from 11 others
$54,651in research payments, 2019–2025

Across 5 payments — averaging $10,930 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medalliance LLC$55K

What the payments were for

  • Consulting fees$52,70568%
  • Speaking & faculty fees$1,0601%
  • Travel & lodging$10,05013%
  • Food & beverage$14,10118%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,916 in reported general payments places this provider in the 90th percentile of 71 interventional cardiology providers in Maryland.

See all interventional cardiology providers in Maryland

Medicare billing

Part B allowed, 2024
$350,777
Medicare patients
1,059
Services billed
2,073

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →